ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Liver carcinoma ruptured | 09.04.02.012; 16.07.02.007 | 0.000208% | | Not Available |
Carbohydrate antigen 19-9 increased | 13.22.01.007 | 0.000278% | | Not Available |
Metastases to abdominal wall | 16.22.02.011; 07.16.05.007 | 0.000347% | | Not Available |
Pulmonary cavitation | 22.01.02.022 | 0.001598% | | Not Available |
Tumour associated fever | 16.32.03.029 | 0.000799% | | Not Available |
Impaired self-care | 19.01.02.014; 08.01.03.071 | 0.000799% | | Not Available |
Lymphangiosis carcinomatosa | 24.09.02.007; 16.22.02.009; 01.09.01.027 | 0.000278% | | Not Available |
Brain natriuretic peptide increased | 13.02.04.011 | 0.000799% | | Not Available |
Clostridium difficile infection | 11.02.02.009 | 0.000799% | | Not Available |
Rectal cancer metastatic | 16.13.01.007; 07.21.05.003 | 0.000417% | | Not Available |
Colon cancer metastatic | 16.13.01.012; 07.21.01.010 | 0.001390% | | Not Available |
Cell death | 14.11.02.005; 08.03.03.003 | 0.000799% | | Not Available |
Hyperphosphatasaemia | 14.11.01.002; 15.02.04.011; 09.01.08.002 | 0.000533% | | Not Available |
Trousseau's syndrome | 24.01.01.033; 16.32.03.028 | 0.000533% | | Not Available |
Female genital tract fistula | 21.10.05.009; 20.08.01.007; 07.11.05.004; 23.07.04.015 | 0.000799% | | Not Available |
International normalised ratio fluctuation | 13.01.02.053 | 0.000533% | | Not Available |
Genital erosion | 21.10.05.015 | 0.000533% | | Not Available |
Nail growth abnormal | 23.02.05.024 | 0.000533% | | Not Available |
Tumour perforation | 16.32.03.031 | 0.000799% | | Not Available |
Stomach mass | 07.11.01.030 | 0.000533% | | Not Available |
Retroperitoneal lymphadenopathy | 07.07.01.012; 01.09.01.029 | 0.000799% | | Not Available |
Hypercreatinaemia | 15.05.03.021; 14.11.01.024 | 0.000533% | | Not Available |
Oral mucosal erythema | 07.05.05.023 | 0.000533% | | Not Available |
Quality of life decreased | 13.18.01.013 | 0.000533% | | Not Available |
Tumour rupture | 16.32.03.033 | 0.000139% | | Not Available |
Metastases to pelvis | 21.07.04.008; 16.22.02.021 | 0.000533% | | Not Available |
Gastrointestinal stromal cancer | 16.13.04.003; 07.21.03.004 | 0.000556% | | Not Available |
Skin wound | 23.03.11.022; 12.01.06.015 | 0.000799% | | Not Available |
Prerenal failure | 20.01.03.022; 24.06.02.025 | 0.000799% | | Not Available |
Abdominal lymphadenopathy | 01.09.01.020; 07.11.01.018 | 0.000799% | | Not Available |